Shahid Aziz Mian
King Fahad Medical City, Saudi Arabia
Title: Clinical exome sequencing of patients from a highly consanguineous population: Novel pathogenic variants impacting neurological function
Biography
Biography: Shahid Aziz Mian
Abstract
Saudi Arabia has a highly consanguineous population with specific geographical regions estimated to have rates exceeding greater than 80%. The downstream effect of such population dynamics is to significantly enrich the
frequency at which recessive pathogenic variants occur and consequently their associated Mendelian disorders.This is evident at both a community and a family level. King Fahad Medical City (KFMC) is a tertiary care facility that diagnoses patients with inherited disorders through exome sequence analysis of germline DNA. Many of the biological pathways negatively impacted by these pathogenic changes manifest at a neurological level. These include for example intellectual disability, ataxia, epilepsy and white matter structural changes. The Department of Pathology and Clinical Laboratory Medicine (PCLM) has sequenced the exomes of over 1100 patients. Novel pathogenic variants in genes biologically and clinically linked to specific neurological conditions have been identified. Furthermore the PCLM knowledge base has also implicated novel genes with no known function, to a variety of neurological conditions. Evidence is presented at how genetic analysis of exome sequence data derived from patients orginating within highly consanguineous populations can lead to the identification of novel genes/genetic variants linked to neurological physiology.